Skip to main content
The Egyptian Heart Journal

Table 1 (2020 ESC Guidelines) for the diagnosis and management of AF

From: Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?: a review article

CHA2DS2-VASc

Score

HAS-BLED

Score

CHF (LVEF < 40%)

1

Hypertension > 160mmHg systolic

1

Hypertension

1

Abnormal renal or liver function

1 or 2

Age ≥ 75 y

2

Stroke

1

Diabetes

1

Previous history of major Bleeding

1

Stroke

2

Labile INR

1

Vascular disease

1

Elderly (Age > 65)

1

Age 65–74

1

Drug or alcohol use—NSAIDs, antiplatelet agents, alcohol > 8 weeks/week

1 or 2

Female sex

1

  
  1. Non-sex CHA2DS2-VASc score of ≥ 2 warrants anticoagulation therapy, while patients with HAS-BLED of ≥ 3 are at higher risk of bleeding. Please note that there are some modifiable risk factors in both scores which clinicians should consider during the management of AF patients and risk balancing between ischemic and embolic risks
Back to article page